News
FDA does a 180, suspending use of Valneva's chikungunya vaccine
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the shot in the United States. | Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq,
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
New indication positions Repatha as an option for high-risk adults with elevated LDL cholesterol and no prior cardiovascular ...
Earlier this month, the FDA backed off on a pause in shipments of the chikungunya vaccine Ixchiq to older adults. Now, the ...
As the HHS and FDA leadership continues to look for ways to boost transparency and reshape the United States' healthcare ...
The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...
Verywell Health on MSN2h
Wegovy Is Now the Second FDA-Approved Treatment for MASH Fibrosis
Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...
The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...
Southwind Foods said it is "voluntarily recalling a limited quantity of frozen shrimp" due to the possible contamination with ...
Some packages of Great Value frozen shrimp sold at Walmart are at risk for potential for Cesium-137 contamination, the FDA ...
The U.S. Food & Drug Administration (FDA) has announced a recall on a limited lot of Blue Bell Ice Cream due to the presence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback